{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T18:21:38Z","timestamp":1755800498558,"version":"3.44.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,8,20]]},"DOI":"10.7759\/cureus.90557","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T09:57:20Z","timestamp":1755683840000},"source":"Crossref","is-referenced-by-count":0,"title":["The Effect of Artificial Oocyte Activation on Blastocyst Development in Patients With Low Blastocyst Rates: A Retrospective Cohort Study"],"prefix":"10.7759","author":[{"given":"Feras","family":"Sendy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Hemmings","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isaac-Jacques","family":"Kadoch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wael","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2009.03.061","article-title":"Artificial oocyte activation and intracytoplasmic sperm injection","volume":"94","author":"Nasr-Esfahani MH","year":"2010","unstructured":"Nasr-Esfahani MH, Deemeh MR, Tavalaee M. Artificial oocyte activation and intracytoplasmic sperm injection. Fertil Steril. 2010, 94:520-6. 10.1016\/j.fertnstert.2009.03.061","journal-title":"Fertil Steril"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dml047","article-title":"Globozoospermia revisited","volume":"13","author":"Dam AH","year":"2007","unstructured":"Dam AH, Feenstra I, Westphal JR, Ramos L, van Golde RJ, Kremer JA. Globozoospermia revisited. Hum Reprod Update. 2007, 13:63-75. 10.1093\/humupd\/dml047","journal-title":"Hum Reprod Update"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dep207","article-title":"Reduced amounts and abnormal forms of phospholipase C zeta (PLC\u03b6) in spermatozoa from infertile men","volume":"24","author":"Heytens E","year":"2009","unstructured":"Heytens E, Parrington J, Coward K, et al.. Reduced amounts and abnormal forms of phospholipase C zeta (PLC\u03b6) in spermatozoa from infertile men. Hum Reprod. 2009, 24:2417-28. 10.1093\/humrep\/dep207","journal-title":"Hum Reprod"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1172\/JCI36942","article-title":"Human sperm devoid of PLC, zeta 1 fail to induce Ca2+ release and are unable to initiate the first step of embryo development","volume":"118","author":"Yoon SY","year":"2008","unstructured":"Yoon SY, Jellerette T, Salicioni AM, et al.. Human sperm devoid of PLC, zeta 1 fail to induce Ca2+ release and are unable to initiate the first step of embryo development. J Clin Invest. 2008, 118:3671-81. 10.1172\/JCI36942","journal-title":"J Clin Invest"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/hropen\/hoac003","article-title":"Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application","volume":"2022","author":"Kashir J","year":"2022","unstructured":"Kashir J, Ganesh D, Jones C, Coward K. Oocyte activation deficiency and assisted oocyte activation: mechanisms, obstacles and prospects for clinical application. Hum Reprod Open. 2022, 2022:10.1093\/hropen\/hoac003","journal-title":"Hum Reprod Open"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deh325","article-title":"Complete oocyte activation failure after ICSI can be overcome by a modified injection technique","volume":"19","author":"Ebner T","year":"2004","unstructured":"Ebner T, Moser M, Sommergruber M, Jesacher K, Tews G. Complete oocyte activation failure after ICSI can be overcome by a modified injection technique. Hum Reprod. 2004, 19:1837-41. 10.1093\/humrep\/deh325","journal-title":"Hum Reprod"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/14.5.1307","article-title":"Successful fertilization and pregnancy following ICSI and electrical oocyte activation","volume":"14","author":"Yanagida K","year":"1999","unstructured":"Yanagida K, Katayose H, Yazawa H, Kimura Y, Sato A, Yanagimachi H, Yanagimachi R. Successful fertilization and pregnancy following ICSI and electrical oocyte activation. Hum Reprod. 1999, 14:1307-11. 10.1093\/humrep\/14.5.1307","journal-title":"Hum Reprod"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2012.07.1134","article-title":"Application of a ready-to-use calcium\u00a0ionophore increases rates of\u00a0fertilization and pregnancy in\u00a0severe male factor infertility","volume":"98","author":"Ebner T","year":"2012","unstructured":"Ebner T, K\u00f6ster M, Shebl O, Moser M, Van der Ven H, Tews G, Montag M. Application of a ready-to-use calcium\u00a0ionophore increases rates of\u00a0fertilization and pregnancy in\u00a0severe male factor infertility. Fertil Steril. 2012, 98:1432-7. 10.1016\/j.fertnstert.2012.07.1134","journal-title":"Fertil Steril"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.11.007","article-title":"Effect of two assisted oocyte activation protocols used to overcome fertilization failure on the activation potential and calcium releasing pattern","volume":"105","author":"Nikiforaki D","year":"2016","unstructured":"Nikiforaki D, Meerschaut FV, de Roo C, Lu Y, Ferrer-Buitrago M, de Sutter P, Heindryckx B. Effect of two assisted oocyte activation protocols used to overcome fertilization failure on the activation potential and calcium releasing pattern. Fertil Steril. 2016, 105:798-806. 10.1016\/j.fertnstert.2015.11.007","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dead184","article-title":"Good practice recommendations on add-ons in reproductive medicine","volume":"38","author":"Lundin K","year":"2023","unstructured":"Lundin K, Bentzen JG, Bozdag G, et al.. Good practice recommendations on add-ons in reproductive medicine. Hum Reprod. 2023, 38:2062-104. 10.1093\/humrep\/dead184","journal-title":"Hum Reprod"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deu285","article-title":"Treatment with Ca2+ ionophore improves embryo development and outcome in cases with previous developmental problems: a prospective multicenter study","volume":"30","author":"Ebner T","year":"2015","unstructured":"Ebner T, Oppelt P, W\u00f6ber M, et al.. Treatment with Ca2+ ionophore improves embryo development and outcome in cases with previous developmental problems: a prospective multicenter study. Hum Reprod. 2015, 30:97-102. 10.1093\/humrep\/deu285","journal-title":"Hum Reprod"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02467-3","article-title":"Effect of A23187 ionophore treatment on human blastocyst development - a sibling oocyte study","volume":"39","author":"Mateizel I","year":"2022","unstructured":"Mateizel I, Santos-Ribeiro S, Segers I, Wouters K, Mackens S, Verheyen G. Effect of A23187 ionophore treatment on human blastocyst development - a sibling oocyte study. J Assist Reprod Genet. 2022, 39:1225-32. 10.1007\/s10815-022-02467-3","journal-title":"J Assist Reprod Genet"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-021-06329-8","article-title":"Efficacy of artificial oocyte activation in patients with embryo developmental problems: a sibling oocyte control study","volume":"305","author":"Yin M","year":"2022","unstructured":"Yin M, Li M, Li W, et al.. Efficacy of artificial oocyte activation in patients with embryo developmental problems: a sibling oocyte control study. Arch Gynecol Obstet. 2022, 305:1225-31. 10.1007\/s00404-021-06329-8","journal-title":"Arch Gynecol Obstet"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2017.06.029","article-title":"Does the use of calcium ionophore during artificial oocyte activation demonstrate an effect on pregnancy rate? A meta-analysis","volume":"108","author":"Murugesu S","year":"2017","unstructured":"Murugesu S, Saso S, Jones BP, et al.. Does the use of calcium ionophore during artificial oocyte activation demonstrate an effect on pregnancy rate? A meta-analysis. Fertil Steril. 2017, 108:468-82. 10.1016\/j.fertnstert.2017.06.029","journal-title":"Fertil Steril"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2014.11.012","article-title":"Live birth after artificial oocyte activation using a ready-to-use ionophore: a prospective multicentre study","volume":"30","author":"Ebner T","year":"2015","unstructured":"Ebner T, Montag M, Montag M, et al.. Live birth after artificial oocyte activation using a ready-to-use ionophore: a prospective multicentre study. Reprod Biomed Online. 2015, 30:359-65. 10.1016\/j.rbmo.2014.11.012","journal-title":"Reprod Biomed Online"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1097\/00001703-199906000-00013","article-title":"Culture and transfer of human blastocysts","volume":"11","author":"Gardner DK","year":"1999","unstructured":"Gardner DK, Schoolcraft WB. Culture and transfer of human blastocysts. Curr Opin Obstet Gynecol. 1999, 11:307-11. 10.1097\/00001703-199906000-00013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2019.04.006","article-title":"Assisted oocyte activation significantly increases fertilization and pregnancy outcome in patients with low and total failed fertilization after intracytoplasmic sperm injection: a 17-year retrospective study","volume":"112","author":"Bonte D","year":"2019","unstructured":"Bonte D, Ferrer-Buitrago M, Dhaenens L, et al.. Assisted oocyte activation significantly increases fertilization and pregnancy outcome in patients with low and total failed fertilization after intracytoplasmic sperm injection: a 17-year retrospective study. Fertil Steril. 2019, 112:266-74. 10.1016\/j.fertnstert.2019.04.006","journal-title":"Fertil Steril"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2019.03.216","article-title":"Artificial oocyte activation improves cycles with prospects of ICSI fertilization failure: a sibling oocyte control study","volume":"39","author":"Li J","year":"2019","unstructured":"Li J, Zheng X, Lian Y, et al.. Artificial oocyte activation improves cycles with prospects of ICSI fertilization failure: a sibling oocyte control study. Reprod Biomed Online. 2019, 39:199-204. 10.1016\/j.rbmo.2019.03.216","journal-title":"Reprod Biomed Online"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.751905","article-title":"Assisted oocyte activation with calcium ionophore improves pregnancy outcomes and offspring safety in infertile patients: a systematic review and meta-analysis","volume":"12","author":"Shan Y","year":"2021","unstructured":"Shan Y, Zhao H, Zhao D, Wang J, Cui Y, Bao H. Assisted oocyte activation with calcium ionophore improves pregnancy outcomes and offspring safety in infertile patients: a systematic review and meta-analysis. Front Physiol. 2021, 12:10.3389\/fphys.2021.751905","journal-title":"Front Physiol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2018.02.015","article-title":"Homozygous mutations in WEE2 cause fertilization failure and female infertility","volume":"102","author":"Sang Q","year":"2018","unstructured":"Sang Q, Li B, Kuang Y, et al.. Homozygous mutations in WEE2 cause fertilization failure and female infertility. Am J Hum Genet. 2018, 102:649-57. 10.1016\/j.ajhg.2018.02.015","journal-title":"Am J Hum Genet"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123899","article-title":"Diagnosis and treatment of male infertility-related fertilization failure","volume":"9","author":"Barber\u00e1n AC","year":"2020","unstructured":"Barber\u00e1n AC, Boel A, Meerschaut FV, Stoop D, Heindryckx B. Diagnosis and treatment of male infertility-related fertilization failure. J Clin Med. 2020, 9:10.3390\/jcm9123899","journal-title":"J Clin Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2022.08.105","article-title":"Artificial oocyte activation with ionomycin compared with A23187 among patients at risk of failed or impaired fertilization","volume":"46","author":"Jia L","year":"2023","unstructured":"Jia L, Chen P, Su W, et al.. Artificial oocyte activation with ionomycin compared with A23187 among patients at risk of failed or impaired fertilization. Reprod Biomed Online. 2023, 46:35-45. 10.1016\/j.rbmo.2022.08.105","journal-title":"Reprod Biomed Online"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2021.07.545","article-title":"First live births after application of a ready-to-use ionomycin in cases of failed artificial oocyte activation (AOA) using calcimycin","volume":"116","author":"Ebner T","year":"2021","unstructured":"Ebner T, Shebl O, Oppelt P. First live births after application of a ready-to-use ionomycin in cases of failed artificial oocyte activation (AOA) using calcimycin. Fertil Steril. 2021, 116:10.1016\/j.fertnstert.2021.07.545","journal-title":"Fertil Steril"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-022-02512-1","article-title":"Effect of A23187 ionophore treatment on human blastocyst development - a sibling oocyte study","volume":"39","author":"Ebner T","year":"2022","unstructured":"Ebner T, Shebl O. Effect of A23187 ionophore treatment on human blastocyst development - a sibling oocyte study. J Assist Reprod Genet. 2022, 39:1233-4. 10.1007\/s10815-022-02512-1","journal-title":"J Assist Reprod Genet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2015.11.017","article-title":"Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division of the oocyte","volume":"105","author":"Capalbo A","year":"2016","unstructured":"Capalbo A, Ottolini CS, Griffin DK, Ubaldi FM, Handyside AH, Rienzi L. Artificial oocyte activation with calcium ionophore does not cause a widespread increase in chromosome segregation errors in the second meiotic division of the oocyte. Fertil Steril. 2016, 105:807-14. 10.1016\/j.fertnstert.2015.11.017","journal-title":"Fertil Steril"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-021-02338-3","article-title":"Ionophore application for artificial oocyte activation and its potential effect on morphokinetics: a sibling oocyte study","volume":"38","author":"Shebl O","year":"2021","unstructured":"Shebl O, Trautner PS, Enengl S, et al.. Ionophore application for artificial oocyte activation and its potential effect on morphokinetics: a sibling oocyte study. J Assist Reprod Genet. 2021, 38:3125-33. 10.1007\/s10815-021-02338-3","journal-title":"J Assist Reprod Genet"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-018-1124-6","article-title":"Obstetric and neonatal outcome following ICSI with assisted oocyte activation by calcium ionophore treatment","volume":"35","author":"Mateizel I","year":"2018","unstructured":"Mateizel I, Verheyen G, Van de Velde H, Tournaye H, Belva F. Obstetric and neonatal outcome following ICSI with assisted oocyte activation by calcium ionophore treatment. J Assist Reprod Genet. 2018, 35:1005-10. 10.1007\/s10815-018-1124-6","journal-title":"J Assist Reprod Genet"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s12958-020-00680-2","article-title":"Risk of birth defects in children conceived by artificial oocyte activation and intracytoplasmic sperm injection: a meta-analysis","volume":"18","author":"Long R","year":"2020","unstructured":"Long R, Wang M, Yang QY, Hu SQ, Zhu LX, Jin L. Risk of birth defects in children conceived by artificial oocyte activation and intracytoplasmic sperm injection: a meta-analysis. Reprod Biol Endocrinol. 2020, 18:10.1186\/s12958-020-00680-2","journal-title":"Reprod Biol Endocrinol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1177\/1933719114542017","article-title":"Health of children born through artificial oocyte activation: a pilot study","volume":"22","author":"Deemeh MR","year":"2015","unstructured":"Deemeh MR, Tavalaee M, Nasr-Esfahani MH. Health of children born through artificial oocyte activation: a pilot study. Reprod Sci. 2015, 22:322-8. 10.1177\/1933719114542017","journal-title":"Reprod Sci"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2013.07.013","article-title":"Neonatal and neurodevelopmental outcome of children aged 3-10 years born following assisted oocyte activation","volume":"28","author":"Meerschaut FV","year":"2014","unstructured":"Meerschaut FV, D'Haeseleer E, Gysels H, et al.. Neonatal and neurodevelopmental outcome of children aged 3-10 years born following assisted oocyte activation. Reprod Biomed Online. 2014, 28:54-63. 10.1016\/j.rbmo.2013.07.013","journal-title":"Reprod Biomed Online"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type","volume":"23","author":"Lambalk CB","year":"2017","unstructured":"Lambalk CB, Banga FR, Huirne JA, et al.. GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. Hum Reprod Update. 2017, 23:560-79. 10.1093\/humupd\/dmx017","journal-title":"Hum Reprod Update"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)61098-x","article-title":"Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial","volume":"8","author":"Aboulghar MA","year":"2004","unstructured":"Aboulghar MA, Mansour RT, Serour GI, Al-Inany HG, Amin YM, Aboulghar MM. Increasing the dose of human menopausal gonadotrophins on day of GnRH antagonist administration: randomized controlled trial. Reprod Biomed Online. 2004, 8:524-7. 10.1016\/s1472-6483(10)61098-x","journal-title":"Reprod Biomed Online"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review","volume":"109","author":"Alviggi C","year":"2018","unstructured":"Alviggi C, Conforti A, Esteves SC, et al.. Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review. Fertil Steril. 2018, 109:644-64. 10.1016\/j.fertnstert.2018.01.003","journal-title":"Fertil Steril"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dev038","article-title":"Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged \u226535 years: a randomized controlled trial","volume":"30","author":"Vuong TN","year":"2015","unstructured":"Vuong TN, Phung HT, Ho MT. Recombinant follicle-stimulating hormone and recombinant luteinizing hormone versus recombinant follicle-stimulating hormone alone during GnRH antagonist ovarian stimulation in patients aged \u226535 years: a randomized controlled trial. Hum Reprod. 2015, 30:1188-95. 10.1093\/humrep\/dev038","journal-title":"Hum Reprod"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/uog.17442","article-title":"Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis","volume":"50","author":"Bechtejew TN","year":"2017","unstructured":"Bechtejew TN, Nadai MN, Nastri CO, Martins WP. Clomiphene citrate and letrozole to reduce follicle-stimulating hormone consumption during ovarian stimulation: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2017, 50:315-23. 10.1002\/uog.17442","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1080\/09513590802404013","article-title":"Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial","volume":"25","author":"Galindo A","year":"2009","unstructured":"Galindo A, Bodri D, Guill\u00e9n JJ, Colodr\u00f3n M, Vernaeve V, Coll O. Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecol Endocrinol. 2009, 25:60-6. 10.1080\/09513590802404013","journal-title":"Gynecol Endocrinol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1002\/rmb2.12440","article-title":"Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin-releasing hormone agonist for women undergoing fertility preservation","volume":"21","author":"Hong YH","year":"2022","unstructured":"Hong YH, Kim SK, Lee JR, Jee BC, Suh CS. Clinical efficacy of dual trigger with human chorionic gonadotropin and a gonadotropin-releasing hormone agonist for women undergoing fertility preservation. Reprod Med Biol. 2022, 21:10.1002\/rmb2.12440","journal-title":"Reprod Med Biol"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deaf097.287","article-title":"O-287 Inter-cycle intra-patient variability in the retrieved oocyte numbers and ovarian response categories between consecutive IVF cycles with identical gonadotropin type, dose, and ovarian stimulation protocol","volume":"40","author":"Hochberg A","year":"2025","unstructured":"Hochberg A, Maman E, Polyzos NP, et al.. O-287 Inter-cycle intra-patient variability in the retrieved oocyte numbers and ovarian response categories between consecutive IVF cycles with identical gonadotropin type, dose, and ovarian stimulation protocol. Hum Reprod. 2025, 40:10.1093\/humrep\/deaf097.287","journal-title":"Hum Reprod"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/399035-the-effect-of-artificial-oocyte-activation-on-blastocyst-development-in-patients-with-low-blastocyst-rates-a-retrospective-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T09:57:21Z","timestamp":1755683841000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/399035-the-effect-of-artificial-oocyte-activation-on-blastocyst-development-in-patients-with-low-blastocyst-rates-a-retrospective-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,20]]},"references-count":38,"URL":"https:\/\/doi.org\/10.7759\/cureus.90557","relation":{},"ISSN":["2168-8184"],"issn-type":[{"type":"print","value":"2168-8184"}],"subject":[],"published":{"date-parts":[[2025,8,20]]}}}